07-24-2014: Johnson & Johnson partnered with Organovo Holdings, Inc. to develop a tissue 3D printing project in a drug discovery setting

It was another announcement promising a revolution in medicine that has yet to arrive...

On July 24, 2014, Organovo – a global pioneer in bioprinting, announced a collaboration with Janssen Research and Development - the Johnson & Johnson company, in the area of 3D printing living tissue for drug research. A year earlier, the company gained worldwide fame by showcasing its advances in bioprinting living liver tissues. Since then, bioprintin…